Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Anti-Cancer Drugs|August 18, 2001
Rituximab as first-line monotherapy in low-grade follicular lymphoma with a low tumor burdenP Solal-CélignyBulletin Du Cancer|September 30, 1998
[Dose-effects and chemotherapy dose intensity of aggressive non-Hodgkin's lymphomas in the adult]P Solal-Céligny, P ColombatLa Revue Du Praticien|September 1, 1993
[Low-grade mucosa-associated lymphoid tissue (MALT) lymphomas]N Brousse, P Solal-CélignyPresse Medicale (Paris, France : 1983)|December 12, 1992
[Pregnancy in patients with essential thrombocythemia. Three cases]P Solal-Céligny, H Fernandez, G TertianArchives of Pathology & Laboratory Medicine|April 1, 1983
The yellow nail syndrome. Light and electron microscopic aspects of the pleuraP Solal-Céligny, Y Cormier, M FournierThe American Review of Respiratory Disease|December 1, 1982
Immune reactions in the lungs of asymptomatic dairy farmersP Solal-Céligny, M Laviolette, J Hébert, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 15, 2008
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatmentG Cartron, M Ohresser, G Salles, et al.Hematological Oncology|January 1, 1994
Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomasG Ganem, P Lambin, G Socié, et al.Clinical Radiology|April 13, 2010
Follicular non-Hodgkin's lymphomaD Hayashi, J C Lee, B Devenney-Cakir, et al.Pageof 2